Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Is the Estimated Industry Valuation for the Minimally Invasive Treatment Of Lung Cancer Sector?
There has been robust growth in the market size of lung cancer’s minimally invasive treatment in the past few years. It is expected to expand from a value of $3.06 billion in 2024 to $3.35 billion in 2025, with a compound annual growth rate (CAGR) of 9.7%. The surge in growth during the historical period can be traced back to the rising incidence of lung cancer, enhanced consciousness about minimally invasive approaches, an increasing elderly population, adoption of early detection techniques, and development of healthcare infrastructure.
The market for minimally invasive lung cancer treatments is set to experience robust expansion in the coming years. The market size is projected to escalate to $4.78 billion in 2029 with a compound annual growth rate (CAGR) of 9.3%. This anticipated growth during the forecast period is largely tied to the escalating demand for outpatient procedures, amplified investments in lung cancer specialized centers, improved accessibility to minimally invasive treatment choices, government-led initiatives towards progressive healthcare, and a concentrated effort to decrease postoperative complications. The projection period will witness trending advancements in surgical instrument technology, breakthroughs in patient monitoring systems, the evolution of precision therapy methods, ramped up research and development in less invasive interventions, and the incorporation of artificial intelligence in treatment planning.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=27349&type=smp
What Forces Are Driving The Growth Of The Minimally Invasive Treatment Of Lung Cancer Market?
The upward trend in lung cancer incidents is anticipated to stimulate the minimally invasive treatment of lung cancer market’s expansion in the future. The surge in lung cancer, which originates in the lungs and involves unrestrained cell growth, can be primarily attributed to the rise in tobacco smoking. This habit heightens the possibility of uncontrolled cell growth and tumour development. Minimally invasive treatment provides a reprieve for lung cancer sufferers by focusing on, isolating or collapsing tumours through small surgical cuts or imaging-guided probes. This approach hastens recovery time, lessens harm to healthy lung tissues, reduces the chance of complications, and expedites the return to everyday activities. For example, in June 2025, the Centers for Disease Control and Prevention, a government agency based in the US, reported that in 2022, there were 218,893 fresh lung cancer incidents in the United States, resulting in 131,584 fatalities. Thus, the mounting incidence of lung cancer is fueling the minimally invasive treatment of lung cancer market’s growth.
How Is The Minimally Invasive Treatment Of Lung Cancer Industry Segmented Across Key Parameters?
The minimally invasive treatment of lung cancer market covered in this report is segmented
1) By Type: Lung Tumor Ablation, Lung Tumor Embolization
2) By Stage: Stage I, Stage II, Stage III, Stage IV
3) By Age Group: Under 30 Years, 31 To 45 Years, 46 To 60 Years
4) By End-User: Hospitals, Ambulatory Surgical Centers (ASCs), Specialty Clinics, Research Institutions
Subsegments:
1) By Lung Tumor Ablation: Radiofrequency Ablation, Microwave Ablation, Cryoablation, Laser Ablation
2) By Lung Tumor Embolization: Bronchial Artery Embolization, Pulmonary Artery Embolization, Chemoembolization, Radioembolization
What Notable Trends Are Shaping The Direction Of The Minimally Invasive Treatment Of Lung Cancer Market?
Leading businesses in the market for minimally intrusive lung cancer treatments are prioritizing the creation of sophisticated systems like fluoroscopic navigation platforms. These platforms are designed to increase precision and facilitate focused, localized therapy for the lungs. These medical imaging systems combine real-time fluoroscopy with navigation technology, enabling precise instrument guidance to the targeted areas of the lung. This technology allows for the minimally invasive biopsy and treatment of difficult-to-reach lesions, thereby lowering the risk of complications. For example, in July 2022, Medtronic plc, a medical technology firm based in Ireland, reported the world’s first endoluminal lung ablation procedure utilizing the ILLUMISITE. The ILLUMISITE platform was used by physicians in Hong Kong in a minimally invasive operation to navigate accurately through a patient’s lungs. It generated a personalized virtual pathway based on the patient’s CT scan. The navigation catheter of the platform directed the bronchoscope to the lung lesion, and a specialized ablation catheter performed the targeted treatment. This achievement marks a notable progress in the diagnosis and treatment of lung masses, integrating precise navigation with localized ablation technology.
Which Companies Currently Dominate The Competitive Landscape In The Minimally Invasive Treatment Of Lung Cancer Industry?
Major companies operating in the minimally invasive treatment of lung cancer market are Johnson & Johnson, Medtronic plc, Siemens Healthineers AG, Stryker Corporation, Boston Scientific Corporation, Olympus Corporation, Intuitive Surgical Inc., Weill Cornell Medicine, Accuray Incorporated, Richard Wolf GmbH, AngioDynamics Inc., CMR Surgical Ltd., Biodesix Inc., Guangzhou Geyi Medical Instrument Co. Ltd., Quantum Surgical SA, Scanlan International Inc., RZ Medizintechnik GmbH & Co. KG, August Reuchlen GmbH, SBH Surgical GmbH & Co. KG, Geister Medizintechnik GmbH.
Get The Full Report Here:
Which Geographic Regions Are Driving Demand In The Minimally Invasive Treatment Of Lung Cancer Market?
North America was the largest region in the minimally invasive treatment of lung cancer market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the minimally invasive treatment of lung cancer market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=27349&type=smp
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model